Krishna Institute Of Medical Sciences Ltd vs Maestros Electronics Telecommun Systems Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Krishna Institute of Medical Sciences Ltd is ₹ 666.15 as of 23 Oct 15:30 . The P/E Ratio of Krishna Institute of Medical Sciences Ltd changed from 33.2 on March 2022 to 103.1 on March 2026 . This represents a CAGR of 25.44% over 5 yearsThe P/E Ratio of Maestros Electronics & Telecommun. Systems Ltd changed from 12.2 on March 2024 to 9.2 on March 2026 . This represents a CAGR of -8.98% over 3 years The Market Cap of Krishna Institute of Medical Sciences Ltd changed from ₹ 11043 crore on March 2022 to ₹ 24910 crore on March 2026 . This represents a CAGR of 17.67% over 5 yearsThe Market Cap of Maestros Electronics & Telecommun. Systems Ltd changed from ₹ 60.31 crore on March 2024 to ₹ 66.4 crore on March 2026 . This represents a CAGR of 3.26% over 3 years The revenue of Krishna Institute of Medical Sciences Ltd for the Jun '26 is ₹ 1196 crore as compare to the Mar '26 revenue of ₹ 1086 crore. This represent the growth of 10.12% The revenue of Maestros Electronics & Telecommun. Systems Ltd for the Jun '26 is ₹ 10.61 crore as compare to the Mar '26 revenue of ₹ 12.81 crore. This represent the decline of -17.17% The ebitda of Krishna Institute of Medical Sciences Ltd for the Jun '26 is ₹ 240.8 crore as compare to the Mar '26 ebitda of ₹ 207.9 crore. This represent the growth of 15.82% The ebitda of Maestros Electronics & Telecommun. Systems Ltd for the Jun '26 is ₹ 2.4 crore as compare to the Mar '26 ebitda of ₹ 3.13 crore. This represent the decline of -23.32% The net profit of Krishna Institute of Medical Sciences Ltd changed from ₹ 95.2 crore to ₹ 37.4 crore over 9 quarters. This represents a CAGR of -33.98% The net profit of Maestros Electronics & Telecommun. Systems Ltd changed from ₹ 1.25 crore to ₹ 1.67 crore over 9 quarters. This represents a CAGR of 13.74% The Dividend Payout of Krishna Institute of Medical Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Maestros Electronics & Telecommun. Systems Ltd changed from 22.04 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 years .

About Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Limited (KIMS) was erstwhile incorporated as Jagjit Singh and Sons Private Limited', a Private Limited Company on July 26, 1973 in Mumbai.
Subsequently, the name of the Company changed to Krishna Institute of Medical Sciences Private Limited' on January 2, 2004 and further upon its conversion to a Public Company, the name was changed to Krishna Institute of Medical Sciences Limited' on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh & Maharashtra providing multi-disciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost.
It is engaged in rendering medical and healthcare services.
It operate 26 multispecialty hospitals under the 'KIMS Hospitals' brand, with an aggregate capacity of over 8600 beds.

About Maestros Electronics & Telecommun. Systems Ltd

Maestros Electronics & Telecommunications Systems Limited was incorporated on February 19, 2010.
At present, Company is engaged in activities pertaining to design, development, and manufacturing of creating products and services for financial inclusion, cardiology, gynecology, critical care patient and diseases management in medicine with rich experience in latest technologies and communication. It provide an advanced portfolio of products and services, including patient monitors, electrocardiographs, defibrillators, pulse oximeters, fetal monitors, stress test systems and much more. With state-of-the-art R&D and manufacturing facilities located in Mumbai, India, Company excel in creating cutting-edge solutions tailored to the needs of clients.
It mainly operates into two segments viz, Electronics & Instrumentation (E&T) and Telemedicine.

FAQs for the comparison of Krishna Institute of Medical Sciences Ltd and Maestros Electronics & Telecommun. Systems Ltd

Which company has a larger market capitalization, Krishna Institute of Medical Sciences Ltd or Maestros Electronics & Telecommun. Systems Ltd?

Market cap of Krishna Institute of Medical Sciences Ltd is 27,978 Cr while Market cap of Maestros Electronics & Telecommun. Systems Ltd is 85 Cr

What are the key factors driving the stock performance of Krishna Institute of Medical Sciences Ltd and Maestros Electronics & Telecommun. Systems Ltd?

The stock performance of Krishna Institute of Medical Sciences Ltd and Maestros Electronics & Telecommun. Systems Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krishna Institute of Medical Sciences Ltd and Maestros Electronics & Telecommun. Systems Ltd?

As of October 25, 2026, the Krishna Institute of Medical Sciences Ltd stock price is INR ₹666.15. On the other hand, Maestros Electronics & Telecommun. Systems Ltd stock price is INR ₹77.7.

How do dividend payouts of Krishna Institute of Medical Sciences Ltd and Maestros Electronics & Telecommun. Systems Ltd compare?

To compare the dividend payouts of Krishna Institute of Medical Sciences Ltd and Maestros Electronics & Telecommun. Systems Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.